Package 51817-171-01

{"route": ["INTRAVENOUS"], "spl_id": "f05916fd-4785-f545-e053-2995a90aa901", "openfda": {"unii": ["02L083W284"], "rxcui": ["1999531"], "spl_set_id": ["3059c2da-d4a7-4aea-828c-20e671cb875c"], "manufacturer_name": ["Pharmascience Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (51817-171-01)  / 10 mL in 1 VIAL", "package_ndc": "51817-171-01", "marketing_start_date": "20180424"}, {"sample": false, "description": "1 VIAL in 1 CARTON (51817-171-02)  / 10 mL in 1 VIAL", "package_ndc": "51817-171-02", "marketing_start_date": "20191215"}], "brand_name": "Ganciclovir", "product_id": "51817-171_f05916fd-4785-f545-e053-2995a90aa901", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "51817-171", "generic_name": "ganciclovir sodium", "labeler_name": "Pharmascience Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ganciclovir", "active_ingredients": [{"name": "GANCICLOVIR SODIUM", "strength": "500 mg/10mL"}], "application_number": "ANDA207645", "marketing_category": "ANDA", "marketing_start_date": "20180424", "listing_expiration_date": "20261231"}